|
|
|
Insider
Information: |
Gordon Carl L |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
11,800 |
|
Indirect Shares
|
43,664,116 |
|
|
Direct
Value |
$15,930 |
|
|
Indirect Value
|
$709,270,056 |
|
|
Total
Shares |
43,675,916 |
|
|
Total
Value |
$709,285,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
1.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2004-06-02 |
0 |
2005-04-20 |
1,395,612 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2005-12-02 |
0 |
2005-12-02 |
1,100,000 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
|
0 |
2011-02-08 |
2,828,941 |
Premium* |
|
Amarin Corp Plc |
AMRN |
Director |
2011-02-28 |
0 |
2012-09-04 |
5,700 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
|
0 |
2013-09-18 |
8,006 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2016-05-11 |
0 |
2016-05-11 |
2,662,180 |
Premium* |
|
Selecta Biosciences Inc |
SELB |
Director, 10% Owner |
|
0 |
2016-06-27 |
1,825,415 |
Premium* |
|
X4 Pharmaceuticals Inc |
XFOR |
Director, 10% Owner |
2017-11-20 |
0 |
2017-11-20 |
1,868,966 |
Premium* |
|
Armo Biosciences Inc |
ARMO |
Director |
2018-01-30 |
0 |
2018-06-22 |
0 |
Premium* |
|
Alector, Inc. |
ALEC |
Director, 10% Owner |
2019-02-11 |
0 |
2019-02-11 |
203,200 |
Premium* |
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
|
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
Director |
2020-04-13 |
0 |
2020-04-13 |
1,119,812 |
Premium* |
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
|
Adicet Bio, Inc |
ACET |
|
2024-06-05 |
11,800 |
2024-06-05 |
11,447,140 |
Premium* |
|
Kinnate Biopharma Inc. |
KNTE |
Director, 10% Owner |
2020-12-07 |
0 |
2024-04-03 |
0 |
Premium* |
|
Terns Pharmaceuticals, Inc. |
TERN |
Director, 10% Owner |
2021-02-09 |
0 |
2022-12-23 |
7,619,135 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
|
0 |
2021-02-05 |
5,826,224 |
Premium* |
|
Theseus Pharmaceuticals, Inc. |
THRX |
Director, 10% Owner |
2021-10-12 |
0 |
2024-02-14 |
0 |
Premium* |
|
Arrivent Biopharma, Inc. |
AVBP |
Director, 10% Owner |
2024-01-30 |
0 |
2024-01-30 |
1,513,664 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2004-06-02 |
4 |
B |
$7.00 |
$1,050,000 |
I/I |
150,000 |
414,403 |
2.1 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2004-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
886,009 |
354,403 |
|
- |
|
ACAD |
Acadia Pharmaceuticals In... |
Director |
|
2005-04-20 |
4 |
B |
$6.79 |
$2,441,704 |
I/I |
359,603 |
774,006 |
2.1 |
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2020-09-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
690,055 |
|
% |
|
ACET |
Adicet Bio, Inc |
Director |
|
2020-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
6,018,452 |
292,607 |
0 |
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2021-02-12 |
4 |
A |
$13.00 |
$6,816,537 |
I/I |
524,349 |
396,657 |
0 |
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2021-12-10 |
4 |
A |
$14.00 |
$2,999,990 |
I/I |
214,285 |
242,285 |
0 |
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,900 |
5,900 |
0 |
- |
|
ACET |
Adicet Bio, Inc |
Director |
|
2023-06-27 |
4 |
B |
$2.09 |
$1,828,750 |
I/I |
875,000 |
748,054 |
2.25 |
% |
|
ACET |
Adicet Bio, Inc |
|
|
2024-01-25 |
4 |
B |
$2.40 |
$7,500,000 |
I/I |
3,125,000 |
1,255,985 |
0.01 |
% |
|
ACET |
Adicet Bio, Inc |
|
|
2024-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,900 |
11,800 |
0 |
- |
|
ALEC |
Alector, Inc. |
Director |
|
2019-02-11 |
4 |
B |
$19.00 |
$7,822,300 |
I/I |
411,700 |
203,200 |
2.25 |
- |
|
ALEC |
Alector, Inc. |
Director |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
12,682,329 |
2,405,292 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-02-28 |
4 |
S |
$7.73 |
$773,000 |
I/I |
(100,000) |
68,000 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-01 |
4 |
S |
$7.56 |
$378,000 |
I/I |
(50,000) |
67,500 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-02 |
4 |
S |
$7.72 |
$733,400 |
I/I |
(95,000) |
66,600 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-03 |
4 |
S |
$7.76 |
$54,320 |
I/I |
(7,000) |
66,500 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-04 |
4 |
S |
$7.62 |
$327,660 |
I/I |
(43,000) |
66,100 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-07 |
4 |
S |
$7.68 |
$192,000 |
I/I |
(25,000) |
65,900 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-11 |
4 |
S |
$7.43 |
$743,000 |
I/I |
(100,000) |
65,000 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-14 |
4 |
S |
$7.33 |
$549,750 |
I/I |
(75,000) |
64,300 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-15 |
4 |
S |
$7.24 |
$362,000 |
I/I |
(50,000) |
63,800 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-21 |
4 |
S |
$7.05 |
$542,850 |
I/I |
(77,000) |
63,100 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-24 |
4 |
S |
$7.50 |
$172,500 |
I/I |
(23,000) |
62,900 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Director |
|
2011-03-25 |
4 |
S |
$7.47 |
$425,043 |
I/I |
(56,900) |
62,400 |
0 |
- |
|
101 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|